New derivative, PEGyAMPH, offers anti-obesity effects without cardiovascular impacts.
🔬 Unlike AMPH, no rise in blood pressure or heart rate.
📊 Enhances insulin sensitivity despite glucose intolerance.
#ObesityResearch #Amphetamines #MetabolicDisorders
https://tnyp.me/kzRoO838/m




